patent/CN-108069952-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108069952-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0152623cff45c7c58e9c47b65ea4ca
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
filingDate	2016-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8b98512c6b2b413b63c66c554c5ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8f5acb45c5b5d41595d95146c2651c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f347195b7948c0f0e5ddc09f49232f57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44a19771716b5efbe7e34cc2db5df1ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20adb3baccb6e129d320c5e945aeba39
publicationDate	2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-108069952-A
titleOfInvention	Quinolinone compounds and their application in medicine
abstract	The present invention relates to quinolinone compounds and their application in medicine, and also relates to a pharmaceutical composition containing said compound and the use of said compound or said pharmaceutical composition in the preparation of medicines, which are used for protection and treatment Or alleviate HIF-associated and/or EPO-associated diseases in patients.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111269177-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111269177-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111269178-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111269176-A
priorityDate	2016-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105384687-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007038571-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465878630 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141515572 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465825368 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467556158

Total number of triples: 36.